Kuwait Genome Editing Market Size & Outlook, 2024-2030
Kuwait genome editing market, 2018-2030 (US$M)
Related Markets
Kuwait genome editing market highlights
- The Kuwait genome editing market generated a revenue of USD 34.3 million in 2023 and is expected to reach USD 74.6 million by 2030.
- The Kuwait market is expected to grow at a CAGR of 11.7% from 2024 to 2030.
- In terms of segment, (crispr)/cas9 was the largest revenue generating technology in 2023.
- (CRISPR)/Cas9 is the most lucrative technology segment registering the fastest growth during the forecast period.
Genome editing market data book summary
| Market revenue in 2023 | USD 34.3 million |
| Market revenue in 2030 | USD 74.6 million |
| Growth rate | 11.7% (CAGR from 2023 to 2030) |
| Largest segment | (crispr)/cas9 |
| Fastest growing segment | (CRISPR)/Cas9 |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | (CRISPR)/Cas9, TALENs/MegaTALs, ZFN, Meganuclease |
| Key market players worldwide | Merck KGaA, Cibus Inc Ordinary Shares - Class A, Recombinetics, Sangamo Therapeutics Inc, Editas Medicine Inc, Precision BioSciences Inc, CRISPR Therapeutics AG, Intellia Therapeutics Inc, Caribou Biosciences Inc Ordinary Shares, Cellectis SA, AstraZeneca PLC, Takara Bio Inc, Horizon Discovery, Danaher Corp, Genscript Biotech Corp Class H, New England Biolabs, Origene Technologies, Bluebird bio Inc, Lonza Group Ltd, Thermo Fisher Scientific Inc |
Other key industry trends
- In terms of revenue, Kuwait accounted for 0.4% of the global genome editing market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Middle East & Africa, Saudi Arabia genome editing market is projected to lead the regional market in terms of revenue in 2030.
- UAE is the fastest growing regional market in Middle East & Africa and is projected to reach USD 166.6 million by 2030.
(crispr)/cas9 was the largest segment with a revenue share of 46.94% in 2024. Horizon Databook has segmented the Kuwait genome editing market based on (crispr)/cas9, talens/megatals, zfn, meganuclease covering the revenue growth of each sub-segment from 2018 to 2030.
The Kuwait genome editing market is expected to witness rapid growth in the coming decade due to the increasing investment in scientific R&D, both by the government and private sector, which drives innovation in genetic technologies. This investment creates opportunities to develop new and improved genome editing tools and techniques.
Furthermore, there is a growing demand for advanced healthcare solutions in Kuwait, including personalized medicine and targeted therapies. Genome editing technologies have the potential to revolutionize healthcare by enabling the development of more precise and effective treatments for a wide range of diseases.
Kuwait's stable economic environment make it an attractive destination for foreign investment in the biotechnology sector, including genome editing. This influx of capital and expertise is expected to further accelerate the growth of the genome editing market in Kuwait.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Genome Editing Market Scope
Genome Editing Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Kuwait genome editing market size, by technology, 2018-2030 (US$M)
Kuwait Genome Editing Market Outlook Share, 2024 & 2030 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
